EP
MEDP icon

Eversept Partners’s Medpace MEDP Stock Holding History

Eversept Partners’s Portfolio MEDP Stock Details MEDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-19,049
Closed -$6.33M – 67
2024
Q4 		$6.33M Buy
+19,049
New +$6.46M 0.56% 36
2023
Q4 		– Sell
-8,823
Closed -$2.14M – 65
2023
Q3 		$2.14M Sell
8,823
-6,741
-43% -$1.72M 0.18% 60
2023
Q2 		$3.74M Buy
15,564
+3,896
+33% +$809K 0.31% 46
2023
Q1 		$2.19M Buy
+11,668
New +$2.41M 0.15% 48

Other funds holding MEDP

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Mawer Investment Management
Mawer Investment Management Calgary, Alberta, Canada $15.4B AUM 10.9% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bessemer Group
Bessemer Group Woodbridge, New Jersey $63.6B AUM 28.76% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Eversept Partners's MEDP Position: Q1 2025 in Review

Eversept Partners sold out of Medpace (MEDP) in Q1 2025, closing a stake of 19,049 shares — an estimated $6.33M sold.

Eversept Partners first reported a position in MEDP in Q1 2023 and held it in 4 quarters. The position peaked at $6.33M in Q4 2024. 586 funds tracked by Wall St. Rank hold MEDP as of Q1 2025.

  • Eversept Partners reported no remaining Medpace position as of Q1 2025 after selling out during the quarter.
  • Eversept Partners sold 19,049 Medpace shares in Q1 2025, an estimated $6.33M.
  • Eversept Partners first reported a position in Medpace in Q1 2023 and held it in 4 quarters.
  • Eversept Partners's Medpace position peaked at $6.33M in Q4 2024.
  • 586 funds tracked by Wall St. Rank held Medpace as of Q1 2025.

Based on Eversept Partners's 13F filing for Q1 2025, filed 15 May 2025.